Compare Stocks: FSNUY, SYK, BSX, and EW

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$43.00 -0.2%	$47.00	$42.20 ▼ $105.65	$62.46B	0.57	19.08 million shs	26.97 million shs
EW Edwards Lifesciences	$84.54 -2.6%	$89.16	$72.30 ▼ $96.29	$49.96B	0.85	2.60 million shs	3.80 million shs
FSNUY Fresenius SE & Co.	$13.09 +0.7%	$12.94	$10.33 ▼ $33.93	$29.29B	0.62	77,886 shs	68,870 shs
SYK Stryker	$275.28 +2.0%	$324.62	$267.00 ▼ $392.55	$103.57B	0.76	2.63 million shs	3.72 million shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	-4.46%	-8.31%	-15.94%	-8.10%	-59.14%
EW Edwards Lifesciences	+0.49%	-3.55%	-7.37%	+1.98%	+10.70%
FSNUY Fresenius SE & Co.	+0.62%	+0.31%	-4.27%	+19.05%	-6.27%
SYK Stryker	-2.18%	-12.36%	-22.27%	-13.51%	-29.55%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSX Boston Scientific	$43.00 -0.2%	$47.00	$42.20 ▼ $105.65	$62.46B	0.57	19.08 million shs	26.97 million shs
EW Edwards Lifesciences	$84.54 -2.6%	$89.16	$72.30 ▼ $96.29	$49.96B	0.85	2.60 million shs	3.80 million shs
FSNUY Fresenius SE & Co.	$13.09 +0.7%	$12.94	$10.33 ▼ $33.93	$29.29B	0.62	77,886 shs	68,870 shs
SYK Stryker	$275.28 +2.0%	$324.62	$267.00 ▼ $392.55	$103.57B	0.76	2.63 million shs	3.72 million shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSX Boston Scientific	-4.46%	-8.31%	-15.94%	-8.10%	-59.14%
EW Edwards Lifesciences	+0.49%	-3.55%	-7.37%	+1.98%	+10.70%
FSNUY Fresenius SE & Co.	+0.62%	+0.31%	-4.27%	+19.05%	-6.27%
SYK Stryker	-2.18%	-12.36%	-22.27%	-13.51%	-29.55%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSX Boston Scientific	2.71	Moderate Buy	$71.46	66.20% Upside
EW Edwards Lifesciences	2.74	Moderate Buy	$100.27	18.61% Upside
FSNUY Fresenius SE & Co.	3.00	Buy	N/A	N/A
SYK Stryker	2.75	Moderate Buy	$380.40	38.19% Upside

Current Analyst Ratings Breakdown

Latest FSNUY, SYK, BSX, and EW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/11/2026	EW Edwards Lifesciences	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$110.00
9/10/2026	SYK Stryker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$399.00 ➝ $360.00
9/9/2026	SYK Stryker	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform	$317.00
9/9/2026	SYK Stryker	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$418.00 ➝ $348.00
9/9/2026	BSX Boston Scientific	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$60.00 ➝ $56.00
8/25/2026	BSX Boston Scientific	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$56.00
8/13/2026	SYK Stryker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/13/2026	SYK Stryker	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Peer Perform
8/6/2026	FSNUY Fresenius SE & Co.	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/3/2026	SYK Stryker	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/3/2026	SYK Stryker	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Market Outperform	$440.00 ➝ $400.00

(Data available from 9/11/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSX Boston Scientific	$21.00B	2.97	$3.86 per share	11.14	$16.49 per share	2.61
EW Edwards Lifesciences	$6.51B	7.48	$2.80 per share	30.22	$17.81 per share	4.75
FSNUY Fresenius SE & Co.	$25.87B	1.14	$1.58 per share	8.26	$9.93 per share	1.32
SYK Stryker	$25.84B	4.09	$16.89 per share	16.30	$58.63 per share	4.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSX Boston Scientific	$2.90B	$2.47	17.41	12.57	1.04	17.50%	19.28%	10.89%	10/28/2026 (Estimated)
EW Edwards Lifesciences	$1.07B	$1.74	48.59	24.94	2.26	15.43%	15.68%	12.05%	10/29/2026 (Estimated)
FSNUY Fresenius SE & Co.	$1.43B	$0.79	16.57	11.38	N/A	6.67%	10.33%	4.87%	11/4/2026 (Estimated)
SYK Stryker	$3.25B	$9.65	28.53	16.42	1.72	14.43%	23.63%	11.39%	10/29/2026 (Estimated)

Latest FSNUY, SYK, BSX, and EW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	FSNUY Fresenius SE & Co.	$0.25	$0.24	-$0.01	$0.20	$6.65 billion	$6.91 billion
7/30/2026	Q2 2026	SYK Stryker	$3.49	$3.69	+$0.20	$3.30	$6.58 billion	$6.59 billion
7/29/2026	Q2 2026	BSX Boston Scientific	$0.83	$0.86	+$0.03	$0.61	$5.38 billion	$5.44 billion
7/23/2026	Q2 2026	EW Edwards Lifesciences	$0.7430	$0.78	+$0.0370	$0.42	$1.70 billion	$1.74 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
FSNUY Fresenius SE & Co.	$0.20	1.53%	N/A	25.32%	N/A
SYK Stryker	$3.52	1.28%	+7.58%	36.48%	32 Years

Latest FSNUY, SYK, BSX, and EW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	SYK Stryker	quarterly	$0.88	1.04%	9/30/2026	9/30/2026	10/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSX Boston Scientific	0.43	1.24	0.74
EW Edwards Lifesciences	0.06	4.52	3.77
FSNUY Fresenius SE & Co.	0.41	1.27	0.98
SYK Stryker	0.59	2.16	1.33

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSX Boston Scientific	89.07%
EW Edwards Lifesciences	79.46%
FSNUY Fresenius SE & Co.	N/A
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
BSX Boston Scientific	0.34%
EW Edwards Lifesciences	0.31%
FSNUY Fresenius SE & Co.	N/A
SYK Stryker	4.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSX Boston Scientific	59,000	1.45 billion	1.44 billion	Optionable
EW Edwards Lifesciences	16,000	575.80 million	574.02 million	Optionable
FSNUY Fresenius SE & Co.	178,394	2.25 billion	N/A	Not Optionable
SYK Stryker	56,000	383.57 million	365.93 million	Optionable

FSNUY, SYK, BSX, and EW Headlines

Recent News About These Companies

Stryker still working through cyberattack after-effects, stock down more than 10% this week

3 hours ago | massdevice.com

Stryker ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses

September 11 at 4:03 PM | newsfilecorp.comN

The Manufacturers Life Insurance Company Acquires 65,333 Shares of Stryker Corporation $SYK

September 11 at 5:27 AM | marketbeat.com

Stryker (NYSE:SYK) Sets New 52-Week Low - Here's What Happened

September 11 at 4:35 AM | americanbankingnews.com

Stryker Corporation $SYK Shares Bought by National Pension Service

September 11 at 4:23 AM | marketbeat.com

Corient Private Wealth LP Reduces Stake in Stryker Corporation $SYK

September 11 at 3:52 AM | marketbeat.com

Stryker stock heads into the open after a 1.95% drop

September 10 at 11:19 PM | ad-hoc-news.deA

Citigroup Issues Pessimistic Forecast for Stryker (NYSE:SYK) Stock Price

September 10 at 12:29 PM | marketbeat.com

Stryker Corporation $SYK Shares Acquired by Tidal Investments LLC

September 10 at 6:08 AM | marketbeat.com

WINTON GROUP Ltd Grows Position in Stryker Corporation $SYK

September 10 at 5:51 AM | marketbeat.com

Securities Fraud Investigation Into Stryker Corporation (SYK) Announced - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

September 9 at 5:15 PM | tmcnet.com

Promising Medical Stocks To Research - September 9th

September 9 at 1:01 PM | marketbeat.com

Securities Fraud Investigation Into Stryker Corporation (SYK) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

September 9 at 11:51 AM | businesswire.com

Stryker (NYSE:SYK) Sets New 12-Month Low - Should You Sell?

September 9 at 4:39 AM | marketbeat.com

Baird Financial Group Inc. Sells 5,319 Shares of Stryker Corporation $SYK

September 9 at 3:12 AM | marketbeat.com

533,784 Shares in Stryker Corporation $SYK Purchased by Veritas Asset Management LLP

September 8 at 7:35 PM | marketbeat.com

SYK ALERT: Stryker Investigated for Securities Fraud by Block & Leviton; Investors Should Contact the Firm

September 8 at 4:14 PM | globenewswire.com

Stryker Corporation (SYK) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

September 8 at 4:00 PM | seekingalpha.com

Top Medical Stocks To Add to Your Watchlist - September 8th

September 8 at 2:01 PM | marketbeat.com

Stryker (NYSE:SYK) Shares Down 6.2% - What's Next?

September 8 at 12:19 PM | marketbeat.com

Why Stryker (SYK) Stock Is Down Today

September 8 at 11:51 AM | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

FSNUY, SYK, BSX, and EW Company Descriptions

Boston Scientific NYSE:BSX

$43.00 -0.10 (-0.24%)

Closing price 03:58 PM Eastern

Extended Trading

$43.12 +0.12 (+0.28%)

As of 07:59 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Edwards Lifesciences NYSE:EW

$84.54 -2.23 (-2.57%)

Closing price 03:58 PM Eastern

Extended Trading

$84.82 +0.28 (+0.33%)

As of 08:00 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Fresenius SE & Co. OTCMKTS:FSNUY

$13.09 +0.09 (+0.69%)

As of 03:59 PM Eastern

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

Stryker NYSE:SYK

$275.28 +5.27 (+1.95%)

Closing price 03:58 PM Eastern

Extended Trading

$276.26 +0.98 (+0.36%)

As of 08:00 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FSNUY, SYK, BSX, and EW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FSNUY, SYK, BSX, and EW Earnings

Compare Dividends

Latest FSNUY, SYK, BSX, and EW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FSNUY, SYK, BSX, and EW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

FSNUY, SYK, BSX, and EW Company Descriptions

Boston Scientific NYSE:BSX

Edwards Lifesciences NYSE:EW

Fresenius SE & Co. OTCMKTS:FSNUY

Stryker NYSE:SYK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools